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Abstract
Background: Periodontium may be able to respond to injuries by regeneration via the function of stem cells.
Objectives: This study sought to assess the differentiation of human periodontal ligament stem cells (PDLSCs) into osteoblasts in
standard osteogenic medium and in a medium supplemented with 1,25-dihydroxyvitamin D3 (calcitriol).
Materials and Methods: In this experimental study, PDLSCs were isolated under sterile conditions by scraping the periodontal
ligament tissues attached to the middle third of the root surface of extracted teeth, which were obtained from patients who were
candidates for orthodontics therapy in the dental faculty at Hamadan University. The collected cells were cultured on four culture
plates for 24 hours. Group 1 contained a basic medium (α-MEM, containing 10% fetal bovine serum (FBS), 5 mMβ-glycerophosphate,
and 50µg/mL l-ascorbic acid), supplemented with 10 - 8 M dexamethasone. Group 2 contained a basic medium supplemented with
vitamin D3. Group 3 contained a basic medium supplemented with vitamin D3 and dexamethasone, Group4 contained negative
control cultures. Alizarin red staining (ARS), alkaline phosphatase (ALP) activity, and calcium content (CC) tests were performed to
evaluate osteogenic differentiation of third passage cells in the developing adherent layer.
Results: Quantitative analysis of ARS demonstrated that mineralized nodule formation was highest in the group supplemented
with calcitriol and dexamethasone (P < 0.001). Results of the ALP test on day 28 demonstrated the highest ALP activity in the group
supplemented with calcitriol (P < 0.001). The amount of CC was lowest in the control group at all-time points, and was highest in
the group supplemented with both calcitriol and dexamethasone on day 28 (P < 0.001).
Conclusions: The combination of calcitriol with dexamethasone, ascorbic acid, and beta-glycerophosphate (that is, the osteogenic
medium) may be beneficial for differentiation of PDLSCs into osteoblasts.
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1. Background
Periodontal treatment is performed with the aim of
stopping progressive attachment loss. However, the ulti-
mate goal of periodontal therapy is to regenerate the lost
supporting structures. Successful periodontal regenera-
tion includes re-establishment of the epithelial seal, for-
mation of connective tissue fibers attached to the root
surface, regeneration of acellular cementum on the root
surface, and obtaining adequate alveolar bone height. To
achieve this goal, several techniques have been recom-
mended for use in the clinical setting, such as guided tissue
regeneration (GTR); implantation of autografts, allografts
or alloplastic materials; chemical root conditioning; use of
growth factors; or a combination of these approaches (1, 2).
one of the newest methods for regenerating lost tissue
is using stem cells. Mesenchymal stem cells have the poten-
tial to differentiate to different cell types (chondrocytes, os-
teoblasts, fibroblasts, adipocytes) and many mesenchymal
tissues. These cells are present in many tissues and organ
(3).
Periodontal ligament (PDL) contains pluripotent stem
cells as a source of periodontal tissue regeneration. It is
believed that periodontal regeneration can be successfully
attained via the migration of periodontal ligament stem
cells (4, 2). Seo et al. verified that only some of the progen-
itor cells of PDL can be considered stem cells. These peri-
odontal adult stem cells have the phenotypic, morpholog-
ical, and proliferative characteristics of adult mesenchy-
mal stem cells (5). These cells are capable of promoting
tissue turnover and homeostasis, serving as a source of
renewable progenitor cells that generate osteoblasts, ce-
mentoblasts, and fibroblasts throughout adult life. In re-
sponse to inflammatory processes, these stem cells are ac-
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tivated by mediators when periodontal tissues are dam-
aged (6, 7). Based on this capability, new methods of tis-
sue regeneration have been developed and some products
have been introduced, such as bone morphogenetic pro-
teins and enamel associated proteins, in attempts to regen-
erate periodontal tissues (8). However, the exact cells re-
sponsible for the regeneration of the periodontium have
yet to be determined. It has been shown that many of the
events required for the development of periodontal tissues
are similar to those required for regeneration of periodon-
tal tissues. In both situations, appropriate cells must be at-
tracted to and attach to the target site. To provide an envi-
ronment appropriate for cell proliferation and differenti-
ation, an appropriate matrix must be secreted by cells for
them to have the capacity to function as PDL fibroblasts, os-
teoblasts, or cementoblasts (9).
Periodontal ligament stem cells are a class of dental ec-
tomesenchymal stem cell that is isolated from the root sur-
face of extracted teeth. These cells can be isolated as plastic-
adherent, colony-forming cells, but under in vitro condi-
tions, they display a low potential for osteogenic differen-
tiation. PDL stem cells differentiate into cells or tissues
very similar to the periodontium (10). PDL stem cells have
demonstrated a capacity for tissue reconstruction and pe-
riodontal repair when transplanted into immunocompro-
mised rats and mice (5). Recently, PDL stem cells also have
been isolated from sheep and pigs (11, 12). It has been
shown that a functional periodontium can be established
successfully by using PDL stem cells (13).
Calcitriol, also known as 1, 25-dihydroxycholecalciferol
or 1, 25-dihydroxyvitamin D3, is the hormonally active
metabolite of vitamin D known for its important role as a
regulator of mineral and bone metabolism. It has a high
affinity for the nuclear vitamin D receptor (14, 15). It can in-
hibit the proliferation and promote the differentiation of
many cell types, especially tumoral cells (16, 17). Epidemi-
ologic and experimental studies have also demonstrated
the anti-tumor effects of calcitriol (18) because it inhibits
cell proliferation (17, 19, 20), arrests cell cycles (16, 21), pro-
motes apoptosis (22, 23), and induces cell differentiation
(24). Vitamin D receptors are present in most if not all cells
in the body. Additionally, experiments using cultured cells
have demonstrated that vitamin D has significant effects
on differentiation of many types of cells into osteoblasts.
These findings suggest that vitamin D may play a role in
mineral homeostasis and bone metabolism (25, 26).
2. Objectives
This is an active area of research. Thus, the present
study was conducted to assess the in vitro effect of cal-
citriol on differentiation of PDLSCs into osteoblasts.
3. Materials andMethods
3.1. Isolation of Periodontal Stem Cells
Stem cells were isolated from the roots of 15 clinically
intact premolars from young patients who had undergone
orthodontic treatment. Patients were visited and scaling
was done 5 to 7 days before teeth extraction (5). If visible
plaque existed before extraction, polishing of the tooth to
be extracted was done again. In order to minimize the risk
of contamination of specimens, prep and drape were done
after local anesthesia. Also, patients were asked to rinse di-
luted povidone iodine with normal saline (1:1), because this
mouth rinse is faster and has stronger effect. Instruments
were precisely sterilized, and surgeon and assistants wore
masks, surgical gowns, and sterile gloves. Extraction had
to be done with minimal wobbling. The surgeon held the
coronal portion of the tooth with forceps and separated
the root part using a disc and high-speed hand piece under
copious saline irrigation, to avoid over-heating and subse-
quent cell damage. After cutting through the tooth thick-
ness, the surgeon used pliers to break the root part. One
assistant opened a sterile tube containing alpha-modified
eagle’s medium (α-MEM), and the root was immediately
placed in the tube. Care was taken not to contact any sur-
faces, even the outer surface of the tube. The tube was cov-
ered and sealed immediately with a wax sheet (27). The
method used to isolate the stem cells was in accord with
that described by Gay et al. as follows:
By using a surgical scalpel, the periodontal ligament
tissues only attached to the middle third of the root surface
were removed to avoid contamination by gingival and pul-
pal cells. Scraped periodontal ligament cells were trans-
ferred to a plate containing α-MEM and 15% fetal bovine
serum (FBS), and enzymatically digested for 1 hour at 37°C
using 3 mg/mL collagenase type I solution. Then the sam-
ples were centrifuged at 400 g for 10 minutes and plates
were expanded with α-MEM containing 15% FBS and 1%
antibiotics in 6-well plates and cultured at 37°C and 5%
CO2. Adherent cells with 80 - 90% confluence were washed
twice with phosphate-buffered saline (PBS) and detached
from the culture surface using 0.25% trypsin-EDTA solution
(Gibco, Germany) and plated in tissue culture polystyrene
flasks at 5 × 103 cells/cm2 on day 7. Primary cultures of
PDLSCs mainly consisted of colonies of bipolar fibroblas-
toid cells, reaching a confluent growth-arrested condition,
after sub-cultivation and proliferating within a population
doubling time of 48 hours (28).
3.2. Osteogenic Differentiation
Cells in the developing adherent layer were used for
osteogenic differentiation after detachment with 0.25%
trypsin-EDTA solution at the third passage. The collected
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cells were cultured in four culture plates for 24 hours. The
culture medium was changed when the confluence of cells
reached 80%, as follows:
Group 1: contained basic medium (α-MEM contain-
ing 10 % FBS, 5 mMβ-glycerophosphate, and 50 µg/mL l-
ascorbic acid) supplemented with 10 - 8 M dexamethasone.
Group 2: contained basic medium supplemented with
vitamin D3.
Group 3: contained basic medium supplemented with
vitamin D3 and dexamethasone.
Group 4: negative control cultures, which were main-
tained in α-MEM containing 10% FBS without osteogenic
supplements. (Vitamin D3 at 10 ng/mL was dissolved in α-
MEM).
Cells were re-fed every 3 days, and then ALP activity was
tested on days 7, 14, 21, and 28. The calcium content (CC)
test was done on days 7, 14, 21, and 28, and the alizarin red
staining (ARS) was performed on day 28 of the subculture
growth. Each group was tested three times and the mean
value was reported.
3.3. Alizarin Red Staining (ARS)
Mineralization of the cell layer was examined using
ARS. The cells were rinsed twice in PBS, fixed in 10%
formaldehyde, and incubated at room temperature for 15
minutes. After rinsing with distilled water, the plates were
stained with 1 mL/well ARS solution (Millipore Co.), incu-
bated at room temperature for at least 20 minutes, and
rinsed with deionized water, after which 1 - 1.5 mL of wa-
ter were added to each well. Differentiated cells containing
mineral deposits were stained bright red by the ARS.
3.4. Quantitative Analysis of ARS
A total of 400µL of acetic acid were added to each well
and incubated for 30 minutes while shaking. With the aid
of a cell scraper, the cells were gently scraped from the
plate, and the cells and acetic acid were transferred to a 1.5
mL micro centrifuge tube. They were then heated to 85°C
for 10 minutes, after which the tube was transferred to an
ice pot for 5 minutes. The slurry was centrifuged at 18000
g for 15 minutes to make a standard solution. The 10x ARS
dilution buffer was diluted 1:10 in distilled H2O, and the
40 mM of ARS solution were diluted 1:20 in 1x ARS dilution
buffer. This gave a 2 mM working stock. Standards could
be prepared in a ‘high range’ or ‘low range’ set. Prepa-
ration of the ‘high range’ set was done by diluting the 2
mM working stock in 2-fold serial dilutions in 1.5 mL mi-
cro centrifuge tubes. To prepare a ‘low range’ set, we be-
gan by first diluting the 2 mM working stock 1:66 (15 µL 2
mM ARS + 985 µL 1X ARS dilution buffer) to achieve a 30
µM working stock. Preparing the ‘low range’ set was done
by further diluting this 30 µM working stock in 2-fold se-
rial dilutions in 1.5 mL micro centrifuge tubes. The blank
consisted of just 1x ARS dilution buffer from which 400 µL
of the supranatant was removed and transferred to a new
1.5 mL micro centrifuge tube. After centrifugation, the pH
was neutralized and 150 µL of the standard sample were
added to an opaque-walled, transparent–bottom, 96-well
plate. It was read at OD405. Alizarin red concentration vs.
OD405 was plotted. The alizarin red quantitative data set is
shown in Figure 1. Each group was tested three times and
the mean value for each group was reported.
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Figure 1. Alizarin Red Quantitative Data Set
3.5. Alkaline Phosphatase (ALP) Activity
In addition to ARS, assessment of osteoblastic differen-
tiation was done by measuring ALP activity in the culture
medium using an ALP kit (Pars Azmun Co, Iran, Tehran).
PDLSCs were cultured as described above, and on days
7 and 14 the used medium in each group was collected
and stored at [U+2012]20°C. To analyze ALP activity, the
collected medium was diluted in a solution containing
four parts of buffer solution (1 M diethanolamine and 0.5
mM Mcl2) and one part of substrate solution (10 mM p-
nitrophenyl phosphatase). ALP activity was determined
colorimetrically with p-nitrophenyl phosphatase as a sub-
strate.
3.6. Calcium Content (CC) Test
On days 7, 14, 21, and 28, the cells were washed in PBS.
The 0.5 mL PBS solution containing 5% Triton X-100 was
added to each well. With the aid of a cell scraper, the cells
were scraped from the plate and stored at [U+2012]20°C.
Then, the cells were frozen and re-frozen 3 times, and
finally the CC in the samples was measured by the o-
cresolphthalein complexone method on days 7, 14, 21, and
28 of subculture growth. The test was done according to
the instructions of Pars Azmun Co.
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3.7. Statistical Analysis
Statistical analysis was done using SPSS version 17 soft-
ware. Deliberation was done using 6 × 3 factorial (six
group’s× three periods). The data then were subjected to
one-way analysis of variance (ANOVA), and the differences
between the groups were compared using Tukey’s post hoc
test. A normal distribution of data was tested by the non-
parametric method using the Kolmogorov-Smirnov test.
4. Results
4.1. Results of Quantitative Analysis of ARS
Quantitative analysis of ARS on day 28 demonstrated
that mineralized nodule formation was the highest in the
group supplemented with vitamin D3 and dexamethasone
(Figure 2). The difference between the vitamin D3 group
and the control group was not significant (P = 0.625), but
the ANOVA test showed that the difference between the vi-
tamin D3 + dexamethasone group and all other groups was
significant (P < 0.001).
0
100
200
300
400
500
600
700
Dex Vit.D Vit.D + Dex Control
M
ic
ro
m
ol
ar
/m
L
Groups
Figure 2. Quantitative Analysis of Alizarin Red Staining in Different Groups
4.2. Results of ALP Activity Test
The ALP activity was measured after 7, 14, 21, and 28 days
of subculture growth to quantify osteoblastic differenti-
ation (Figure 3). After 28 days of subculture growth, the
highest ALP activity was seen in the group supplemented
with vitamin D3. The differences between the vitamin D3
and vitamin D3 + dexamethasone groups was not signifi-
cant, but the ANOVA test showed that there was a signifi-
cant difference in this regard between all other groups (P
< 0.001).
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Figure 3. ALP Activity Test in Different Groups After 28 Days of Subculture Growth
4.3. Results of CC Test
The CC test was done at 7, 14, 21, and 28 days of subcul-
ture growth and demonstrated that the amount of calcium
in the group supplemented with dexamethasone + vita-
min D3 was the highest (Figure 4). The ANOVA test showed
that there was a significant difference between the control
group and all other groups (P < 0.001). Moreover, the dif-
ference between the vitamin D and vitamin D + dexametha-
sone groups was significant as well (P < 0.001).but the dif-
ference between the dexamethasone and vitamin D + dex-
amethasone groups was not significant (P = 0.5).
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Figure 4. Intracellular Calcium Deposition in Different Groups After 28 Days of Sub-
culture Growth
4.4. Changes in ALP Activity
There was a slight increase in ALP activity in the control
group during the study (Figure 5). In this group, the level
of ALP on days 7, 14, 21, and 28 was 12.5, 14.0, 14.5, and 16.0
U/L, respectively. The amount of ALP in the dexamethasone
group on days 7, 14, 21, and 28 was 127, 613, 583, and 365 U/L,
respectively. These values in the vitamin D3 group were 133,
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620, 621, and 623 U/L, respectively. In the vitamin D3 and
dexamethasone group, these values were 173, 284, 487, and
608 U/L, respectively.
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Figure 5. Changes in ALP Activity in the Control Group
5. Discussion
Bone regeneration is an important topic, and many
researchers have focused on methods and materials to
achieve this goal. Considering the optimal properties of
systemic vitamin D3 and its role in bone remodeling, de-
creasing the risk of bone fracture, and enhancing wound
healing, this study sought to assess the effect of vitamin D3
on differentiation of PDLSCs into osteoblasts. In order to
study the effects of calcitriol on osteogenesis, we used ALP
activity, and CC and ARS tests at 7, 14, 21, and 28 days. ALP
is present in the cell membrane of osteoblasts, and any in-
crease in its activity indicates the differentiation of stem
cells into osteoblasts (9). Although the combination of vi-
tamin D3 and dexamethasone increased the activity of ALP
in our study, the addition of vitamin D3 alone showed the
same effect as well. At 7 and 14 days, dexamethasone in-
creased the activity of ALP, but it later decreased at 21 and 28
days; whereas ALP activity did not decline in the vitamin D3
group after day 14. Our results regarding the effect of cal-
citriol on increasing ALP activity were somewhat in accord
with those of Geng et al. They evaluated the effect of 25-
hydroxyvitamin D3 on proliferation and osteoblastic dif-
ferentiation of human marrow stromal cells, and demon-
strated inhibition of proliferation and promotion of dif-
ferentiation by calcitriol (29). Although type of stem cells
used in their study was different from ours, the same ef-
fects were noted for calcitriol on these cells as in our study.
Moreover, Tang and Meng demonstrated that osteogenic
induction significantly enhanced the proliferation of hu-
man periodontal ligament cells, whereas calcitriol inhib-
ited their proliferation (25). These findings are somewhat
in accord with our results as well. Zur Nieden et al. in
2003 showed differentiation of embryonic stem cells into
mineralized osteoblasts due to exposure to ascorbic acid,
beta-glycerophosphate, and 1-alpha, 25-OH vitamin D3. ALP
activity increased at of culture growth, and mineralized
cells were detected by histochemical staining. Expression
of osteopontin and osteonectin (involved in the process of
binding calcium ions and hydroxyapatite during the min-
eralization process) was also enhanced at the beginning of
the second culture week. ALP activity increased again at the
beginning of the third week of culture growth and was en-
hanced again at later stages of culture growth at days 27
- 34. Although their study was conducted on mouse em-
bryonic stem cells, results similar to our outcome were ob-
tained regarding the effect of 1-alpha, 25-OH vitamin D3 on
induction of osteoblast differentiation (30).
Most of the actions of vitamin D3 are mediated
through a nuclear factor known as the vitamin D recep-
tor (VDR) (31). Upon entering the nucleus of a cell, 1, 25-
dihydroxyvitamin D3 adheres to the VDR and promotes
its association with the retinoic acid X receptor (RXR). In
the presence of 1, 25-dihydroxyvitamin D3, the VDR/RXR
complex binds small sequences of DNA, known as vitamin
D response elements (VDREs), and initiates a cascade of
molecular interactions that modulate the transcription of
specific genes. More than 50 human genes are known to
be regulated by 1, 25-dihydroxyvitamin D3 (14). Tang and
Meng demonstrated that calcitriol significantly increased
the level of VDR by three-fold (25).
The special kit used for ARS in this study enabled ex-
amining the quantitative ARS to compare the amount of
mineralized nodules formed. The results of ARS showed
that dexamethasone had a significant effect on formation
of mineralized nodules, indicative of osteogenic differen-
tiation, which is in accord with the results of Langenbach
and Handschel (32); vitamin D3 alone had no significant ef-
fect in this regard. The combination of vitamin D3 and dex-
amethasone again significantly enhanced osteoblastic dif-
ferentiation. These results were confirmed by the CC test
as well. A significant increase was observed in the CC for
all groups, in contrast to the control group. However, the
combination of vitamin D3 and dexamethasone caused a
greater increase in this regard. Compared to vitamin D3
along, dexamethasone was more effective on the CC of the
cells, and based on our results presence of vitamin D3 was
necessary for this effect.
Future studies are recommended to assess the effect
of different doses of tested materials, in order to find the
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most effective dosage. Moreover, animal studies are re-
quired to better elucidate the effect of calcitriol on PDLSCs,
and to obtain results that can be more generalized to the
clinical setting.
5.1. Conclusions
The combination of vitamin D3, dexamethasone,
ascorbic acid, and beta-glycerophosphate (the osteogenic
medium) may enhance the differentiation of PDL stem
cells into osteoblasts.
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